Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,622,900 | 2,459,200 | 3,818,500 | 3,788,200 | 3,220,000 |
| Marketable Securities | 113,800 | 109,100 | 90,100 | 37,100 | 51,200 |
| Receivables | 7,672,400 | 7,805,700 | 8,127,200 | 7,025,000 | 6,902,800 |
| Inventories | 3,899,400 | 3,893,000 | 3,886,000 | 3,907,400 | 3,824,900 |
| TOTAL | $17,115,200 | $16,964,700 | $18,452,400 | $17,808,300 | $17,295,500 |
| Non-Current Assets | |||||
| PPE Net | 9,128,200 | 9,102,700 | 8,985,100 | 8,920,400 | 8,855,500 |
| Investments And Advances | 2,587,200 | 2,727,300 | 3,212,600 | 3,350,500 | 3,474,900 |
| Intangibles | 7,497,700 | 7,482,400 | 7,691,900 | 7,887,700 | 7,985,400 |
| Other Non-Current Assets | 10,735,300 | 10,642,200 | 10,464,000 | 10,220,100 | 10,197,700 |
| TOTAL | $29,948,400 | $29,954,600 | $30,353,600 | $30,378,700 | $30,513,500 |
| Total Assets | $47,063,600 | $46,919,300 | $48,806,000 | $48,187,000 | $47,809,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,659,300 | 1,433,300 | 1,670,600 | 1,566,800 | 1,597,800 |
| Other current liabilities | 10,830,700 | 9,998,500 | 10,831,400 | 10,348,700 | 10,416,200 |
| TOTAL | $15,620,600 | $13,386,000 | $15,052,700 | $13,682,000 | $15,093,200 |
| Non-Current Liabilities | |||||
| Long Term Debt | 14,692,000 | 15,152,900 | 15,346,400 | 15,522,400 | 14,736,600 |
| Other Non-Current Liabilities | 7,229,300 | 7,632,300 | 7,518,400 | 9,396,000 | 9,458,400 |
| TOTAL | $22,783,800 | $24,071,300 | $24,598,500 | $26,550,900 | $26,052,300 |
| Total Liabilities | $38,404,400 | $37,457,300 | $39,651,200 | $40,232,900 | $41,145,500 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 950,175 | 950,160 | 952,347 | 956,592 | 956,581 |
| Common Shares | 594,100 | 594,100 | 596,300 | 598,200 | 598,100 |
| Retained earnings | 8,556,000 | 9,369,400 | 8,958,500 | 9,639,400 | 8,530,100 |
| Other shareholders' equity | -7,185,900 | -7,106,800 | -7,180,400 | -8,988,500 | -9,080,900 |
| TOTAL | $8,659,200 | $9,462,000 | $9,154,800 | $7,954,100 | $6,663,500 |
| Total Liabilities And Equity | $47,063,600 | $46,919,300 | $48,806,000 | $48,187,000 | $47,809,000 |